메뉴 건너뛰기




Volumn 77, Issue 2, 2014, Pages 295-301

Benzodiazepine harm: How can it be reduced?

Author keywords

adverse effects; benzodiazepines; reduction of harm

Indexed keywords

ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYPNOTIC AGENT; MUSCLE RELAXANT AGENT;

EID: 84893152500     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2012.04418.x     Document Type: Article
Times cited : (223)

References (48)
  • 2
    • 80455160095 scopus 로고    scopus 로고
    • Benzodiazepines revisited - Will we ever learn?
    • Lader M,. Benzodiazepines revisited-will we ever learn? Addiction 2011; 106: 2086-2109.
    • (2011) Addiction , vol.106 , pp. 2086-2109
    • Lader, M.1
  • 4
    • 0028062989 scopus 로고
    • Differential acute psychomotor and cognitive effects of diazepam on long-term benzodiazepine users
    • Gorenstein C, Bernik MA, Pompeia S,. Differential acute psychomotor and cognitive effects of diazepam on long-term benzodiazepine users. Int Clin Psychopharmacol 1994; 9: 145-153.
    • (1994) Int Clin Psychopharmacol , vol.9 , pp. 145-153
    • Gorenstein, C.1    Bernik, M.A.2    Pompeia, S.3
  • 5
    • 0022971978 scopus 로고
    • Tranquillising memories: A review of the effects of benzodiazepines on human memory
    • Curran H,. Tranquillising memories: a review of the effects of benzodiazepines on human memory. Biol Psychol 1986; 23: 179-213.
    • (1986) Biol Psychol , vol.23 , pp. 179-213
    • Curran, H.1
  • 6
    • 1042291095 scopus 로고    scopus 로고
    • Cognitive effects of long-term benzodiazepine use: A meta-analysis
    • Barker MJ, Greenwood KM, Jackson M, Crowe SF,. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs 2004; 18: 37-48.
    • (2004) CNS Drugs , vol.18 , pp. 37-48
    • Barker, M.J.1    Greenwood, K.M.2    Jackson, M.3    Crowe, S.F.4
  • 7
    • 14944355737 scopus 로고    scopus 로고
    • Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies
    • Verdoux H, Lagnaoui R, Begaud B,. Is benzodiazepine use a risk factor for cognitive decline and dementia? A literature review of epidemiological studies. Psychol Med 2005; 35: 307-315.
    • (2005) Psychol Med , vol.35 , pp. 307-315
    • Verdoux, H.1    Lagnaoui, R.2    Begaud, B.3
  • 8
    • 79955625887 scopus 로고    scopus 로고
    • Benzodiazepines, opioids and driving: An overview of the experimental research
    • Leung SY,. Benzodiazepines, opioids and driving: an overview of the experimental research. Drug Alcohol Rev 2011; 30: 281-286.
    • (2011) Drug Alcohol Rev , vol.30 , pp. 281-286
    • Leung, S.Y.1
  • 9
    • 0018759763 scopus 로고
    • Minor tranquillisers and road accidents
    • Skegg DCC, Richards SM, Doll R,. Minor tranquillisers and road accidents. BMJ 1979; 1: 917-919.
    • (1979) BMJ , vol.1 , pp. 917-919
    • Skegg, D.C.C.1    Richards, S.M.2    Doll, R.3
  • 10
    • 78751615961 scopus 로고    scopus 로고
    • Effects of benzodiazepines, antidepressants and opioids on driving: A systematic review and meta-analysis of epidemiological and experimental evidence
    • Dassanayake T, Michie P, Carter G, Jones A,. Effects of benzodiazepines, antidepressants and opioids on driving: a systematic review and meta-analysis of epidemiological and experimental evidence. Drug Saf 2011; 34: 125-156.
    • (2011) Drug Saf , vol.34 , pp. 125-156
    • Dassanayake, T.1    Michie, P.2    Carter, G.3    Jones, A.4
  • 12
    • 79952234120 scopus 로고    scopus 로고
    • The additive effects of alcohol and benzodiazepines on driving
    • Maxwell HG, Dubois S, Weaver B, Bédard M,. The additive effects of alcohol and benzodiazepines on driving. Can J Public Health 2010; 101: 353-357.
    • (2010) Can J Public Health , vol.101 , pp. 353-357
    • Maxwell, H.G.1    Dubois, S.2    Weaver, B.3    Bédard, M.4
  • 14
    • 0036897827 scopus 로고    scopus 로고
    • Benzodiazepines and disinhibition: A review
    • Paton C,. Benzodiazepines and disinhibition: a review. Psychiatr Bull 2002; 26: 460-462.
    • (2002) Psychiatr Bull , vol.26 , pp. 460-462
    • Paton, C.1
  • 16
    • 68049106370 scopus 로고    scopus 로고
    • The association between dementia and long-term use of benzodiazepine in the elderly: Nested case-control study using claims data
    • Wu CS, Wang SC, Chang IS, Lin KM,. The association between dementia and long-term use of benzodiazepine in the elderly: nested case-control study using claims data. Am J Geriatr Psychiatry 2009; 17: 614-620.
    • (2009) Am J Geriatr Psychiatry , vol.17 , pp. 614-620
    • Wu, C.S.1    Wang, S.C.2    Chang, I.S.3    Lin, K.M.4
  • 17
  • 18
    • 0042349036 scopus 로고    scopus 로고
    • The pharmacotherapy of insomnia: Efficacy and rebound with hypnotic drugs. Primary Care Companion
    • Dikeos DC, Soldatos CR,. The pharmacotherapy of insomnia: efficacy and rebound with hypnotic drugs. Primary Care Companion. J Clin Psychiatry 2002; 4: (Suppl 1): 27-32.
    • (2002) J Clin Psychiatry , vol.4 , Issue.SUPPL. 1 , pp. 27-32
    • Dikeos, D.C.1    Soldatos, C.R.2
  • 19
    • 1542315612 scopus 로고    scopus 로고
    • Chronic benzodiazepine usage and withdrawal in insomnia patients
    • Poyares D, Guilleminault C, Ohayon MM, Tufik S,. Chronic benzodiazepine usage and withdrawal in insomnia patients. J Psychiatr Res 2004; 38: 327-334.
    • (2004) J Psychiatr Res , vol.38 , pp. 327-334
    • Poyares, D.1    Guilleminault, C.2    Ohayon, M.M.3    Tufik, S.4
  • 20
    • 0025453075 scopus 로고
    • Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: A placebo-controlled evaluation of efficacy and daytime anxiety
    • Fontaine R, Beaudry P, Le Morvan P, Beauclair L, Chouinard G,. Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: a placebo-controlled evaluation of efficacy and daytime anxiety. Int Clin Psychopharmacol 1990; 5: 173-183.
    • (1990) Int Clin Psychopharmacol , vol.5 , pp. 173-183
    • Fontaine, R.1    Beaudry, P.2    Le Morvan, P.3    Beauclair, L.4    Chouinard, G.5
  • 21
    • 0023600703 scopus 로고
    • Long-term anxiolytic therapy: The issue of drug withdrawal
    • Lader M,. Long-term anxiolytic therapy: the issue of drug withdrawal. J Clin Psychiatry 1987; 48: (Suppl): 12-16.
    • (1987) J Clin Psychiatry , vol.48 , Issue.SUPPL. , pp. 12-16
    • Lader, M.1
  • 22
    • 0023223770 scopus 로고
    • Benzodiazepine withdrawal: Outcome in 50 patients
    • Ashton H,. Benzodiazepine withdrawal: outcome in 50 patients. Br J Addict 1987; 82: 655-671.
    • (1987) Br J Addict , vol.82 , pp. 655-671
    • Ashton, H.1
  • 24
    • 0030872641 scopus 로고    scopus 로고
    • High prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R and ICD-10 criteria
    • Kan CC, Breteler MHM, Zitmann FG,. High prevalence of benzodiazepine dependence in out-patient users, based on the DSM-III-R and ICD-10 criteria. Acta Psychiatr Scand 1997; 96: 85-93.
    • (1997) Acta Psychiatr Scand , vol.96 , pp. 85-93
    • Kan, C.C.1    Breteler, M.H.M.2    Zitmann, F.G.3
  • 26
    • 42449093133 scopus 로고    scopus 로고
    • UK Department of Health and the Devolved Administrations. London: Department of Health.
    • UK Department of Health and the Devolved Administrations. Drug Misuse and Dependence: UK Guidelines on Clinical Management. London: Department of Health, 2007.
    • (2007) Drug Misuse and Dependence: UK Guidelines on Clinical Management
  • 27
    • 84859092587 scopus 로고    scopus 로고
    • Hypnotic association with mortality or cancer; A matched cohort study
    • Kripke DF, Langer RD, Kline LE,. Hypnotic association with mortality or cancer; a matched cohort study. BMJ Open 2012; 2: e000850.
    • (2012) BMJ Open , vol.2
    • Kripke, D.F.1    Langer, R.D.2    Kline, L.E.3
  • 32
    • 79952795159 scopus 로고    scopus 로고
    • Efficacy of drug treatments for generalised anxiety disorder; Systematic review and meta-analysis
    • Baldwin D, Woods R, Lawson R, Taylor D,. Efficacy of drug treatments for generalised anxiety disorder; systematic review and meta-analysis. BMJ 2011; 342: d1199.
    • (2011) BMJ , vol.342
    • Baldwin, D.1    Woods, R.2    Lawson, R.3    Taylor, D.4
  • 33
    • 67650076600 scopus 로고    scopus 로고
    • Hypnotics. How effective are they for insomnia?
    • Lader MH,. Hypnotics. How effective are they for insomnia? Psychiatr Times 2009; May: 23-25.
    • (2009) Psychiatr Times , pp. 23-25
    • Lader, M.H.1
  • 35
    • 28044462641 scopus 로고    scopus 로고
    • Sedative hypnotics in older people with insomnia: Meta-analysis of risks and benefits
    • Glass J, Lanctot KL, Herrmann N, Sproule BA, Busto UE,. Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 2005; 331: 1169-1173.
    • (2005) BMJ , vol.331 , pp. 1169-1173
    • Glass, J.1    Lanctot, K.L.2    Herrmann, N.3    Sproule, B.A.4    Busto, U.E.5
  • 36
    • 79251552075 scopus 로고    scopus 로고
    • National Institute for Health and Clinical Excellence Clinical Guideline 113. March. London: National Institute for Health and Clinical Excellence
    • National Institute for Health and Clinical Excellence. Anxiety. Generalised anxiety disorder and panic disorder (with or without agoraphobia) in adults. Clinical Guideline 113. March 2011. London: National Institute for Health and Clinical Excellence.
    • (2011) Anxiety. Generalised Anxiety Disorder and Panic Disorder (With or Without Agoraphobia) in Adults
  • 37
    • 77953208053 scopus 로고    scopus 로고
    • Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia
    • National Institute for Health and Clinical Excellence April. London: National Institute for Health and Clinical Excellence
    • National Institute for Health and Clinical Excellence. Guidance on the use of zaleplon, zolpidem and zopiclone for the short-term management of insomnia. Technology Appraisal 77. April 2004. London: National Institute for Health and Clinical Excellence.
    • (2004) Technology Appraisal , vol.77
  • 38
    • 78650412869 scopus 로고    scopus 로고
    • Prolonged-release melatonin in the treatment of primary insomnia: Evaluation of the age cut-off for short- and long-term response
    • Wade AG, Ford I, McConnachie A, Nir T, Laudon M, Zisapel N,. Prolonged-release melatonin in the treatment of primary insomnia: evaluation of the age cut-off for short- and long-term response. Curr Med Res Opin 2011; 27: 78-98.
    • (2011) Curr Med Res Opin , vol.27 , pp. 78-98
    • Wade, A.G.1    Ford, I.2    McConnachie, A.3    Nir, T.4    Laudon, M.5    Zisapel, N.6
  • 39
    • 56549087837 scopus 로고    scopus 로고
    • Antidepressants for the treatment of insomnia; A suitable approach?
    • Wiegand MH,. Antidepressants for the treatment of insomnia; a suitable approach? Drugs 2008; 68: 2411-2417.
    • (2008) Drugs , vol.68 , pp. 2411-2417
    • Wiegand, M.H.1
  • 40
    • 38549115222 scopus 로고    scopus 로고
    • National Center on Addiction and Substance Abuse at Columbia University. New York: Columbia University.
    • National Center on Addiction and Substance Abuse at Columbia University. You've Got Drugs! Prescription Drug Pushers on the Internet. New York: Columbia University, 2006.
    • (2006) You'Ve Got Drugs! Prescription Drug Pushers on the Internet
  • 42
    • 57649126174 scopus 로고    scopus 로고
    • Effectiveness of current treatment approaches for benzodiazepine discontinuation; A meta-analysis
    • Parr JM, Kavanagh DJ, Cahill L, Mitchell G, Young RM,. Effectiveness of current treatment approaches for benzodiazepine discontinuation; a meta-analysis. Addiction 2008; 104: 13-24.
    • (2008) Addiction , vol.104 , pp. 13-24
    • Parr, J.M.1    Kavanagh, D.J.2    Cahill, L.3    Mitchell, G.4    Young, R.M.5
  • 43
    • 0345377740 scopus 로고    scopus 로고
    • Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering; A randomized trial
    • Baillargeon L, Landreville P, Verreault R, Beauchemin J-P, Grégoire JP, Morin CM,. Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering; a randomized trial. Can Med Assoc J 2003; 169: 1015-1020.
    • (2003) Can Med Assoc J , vol.169 , pp. 1015-1020
    • Baillargeon, L.1    Landreville, P.2    Verreault, R.3    Beauchemin, J.-P.4    Grégoire, J.P.5    Morin, C.M.6
  • 44
    • 33750107239 scopus 로고    scopus 로고
    • Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings
    • CD005194.
    • Denis C, Fatseas M, Lavie E, Auriacombe M,. Pharmacological interventions for benzodiazepine mono-dependence management in outpatient settings. Cochrane Database Syst Rev 2006; (3) CD005194.
    • (2006) Cochrane Database Syst Rev , Issue.3
    • Denis, C.1    Fatseas, M.2    Lavie, E.3    Auriacombe, M.4
  • 45
    • 84860112471 scopus 로고    scopus 로고
    • Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: A double-blind, placebo-controlled trial
    • Hadley SJ, Mandel F, Schweitzer E,. Switching from long-term benzodiazepine therapy to pregabalin in patients with generalized anxiety disorder: a double-blind, placebo-controlled trial. J Psychopharmacol 2012; 26: 461-470.
    • (2012) J Psychopharmacol , vol.26 , pp. 461-470
    • Hadley, S.J.1    Mandel, F.2    Schweitzer, E.3
  • 46
    • 83455210179 scopus 로고    scopus 로고
    • Benzodiazepine discontinuation with prolonged-release melatonin: Hints from a German longitudinal prescription database
    • Kunz D, Bineau S, Mmaman K, Milea D, Toumi M,. Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database. Expert Opin Pharmacother 2012; 13: 9-16.
    • (2012) Expert Opin Pharmacother , vol.13 , pp. 9-16
    • Kunz, D.1    Bineau, S.2    Mmaman, K.3    Milea, D.4    Toumi, M.5
  • 47
    • 57449093853 scopus 로고    scopus 로고
    • Withdrawing benzodiazepines in primary care
    • Lader M, Tylee A, Donoghue J,. Withdrawing benzodiazepines in primary care. CNS Drugs 2009; 23: 19-34.
    • (2009) CNS Drugs , vol.23 , pp. 19-34
    • Lader, M.1    Tylee, A.2    Donoghue, J.3
  • 48
    • 14844288465 scopus 로고    scopus 로고
    • Benzodiazepine use, abuse and dependence
    • O'Brien CP,. Benzodiazepine use, abuse and dependence. J Clin Psychiatry 2005; 66: (Suppl 2): 28-33.
    • (2005) J Clin Psychiatry , vol.66 , Issue.SUPPL. 2 , pp. 28-33
    • O'Brien, C.P.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.